Macrogenics (MGNX) Accumulated Expenses (2012 - 2026)

Macrogenics (MGNX) has 15 years of Accumulated Expenses data on file, last reported at $18.4 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $18.4 million, down 33.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.4 million (down 33.74% YoY), and the FY2025 annual result was $22.2 million, down 24.22% from the prior year.
• Accumulated Expenses fell to $18.4 million in Q1 2026 per MGNX's latest filing, from $22.2 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $33.3 million in Q3 2022 and troughed at $18.1 million in Q1 2024.
• A 5-year average of $26.0 million and a median of $25.5 million in 2023 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses plunged 35.62% in 2024, then surged 53.39% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $29.0 million in 2022, then slipped by 16.41% to $24.2 million in 2023, then gained by 21.02% to $29.3 million in 2024, then declined by 24.22% to $22.2 million in 2025, then declined by 17.02% to $18.4 million in 2026.
• Business Quant data shows MGNX's Accumulated Expenses at $18.4 million in Q1 2026, $22.2 million in Q4 2025, and $23.1 million in Q3 2025.